06/06/2016

CURES webinar recording now available


CDA recently hosted a webinar, presented by the Department of Justice, to assist member dentists with the Controlled Substance Utilization Review and Evaluation System (CURES 2.0) registration process and any questions they may have regarding the new system. For the convenience of CDA members, the recorded webinar, which offers dentists important CURES registration tips, is now available on cda.org by clicking on the "CURES webinar" icon on the right side of the homepage.

All prescribers in California with U.S. Drug Enforcement Administration registrations are required to register by July 1 to access California's prescription drug monitoring program, designed to aid prescribers and dispensers in identifying fraudulent or drug-seeking activity by a patient. Dentists are strongly encouraged to consult CURES when considering a controlled substance prescription for a new patient or a patient suspected of drug dependency.

To register for CURES 2.0, visit oag.ca.gov/cures.



Related Items

All prescribers in California with U.S. Drug Enforcement Administration registrations are required to register by July 1 to access California’s prescription drug monitoring program, known as CURES 2.0 (Controlled Substance Utilization Review and Evaluation System).

All prescribers in California with U.S. Drug Enforcement Administration (DEA) registrations are required to register by July 1 to access California's prescription drug monitoring program, known as CURES 2.0 (Controlled Substance Utilization Review and Evaluation System). Here are some common questions and answers for dentists related to the use of CURES.

Topics
Top